Trident Texofab Ltd - 540726 - Announcement Under Regulation 30(LODR)-Investor Presentation
Please find attached the Investor Presentation of the Financial Results for the Quarter and Half year ended september 30, 2019.04-12-2019
04-12-2019
Trident Texofab Ltd - 540726 - Revised Financial Result For The Quarter And Half Year Ended On September 30, 2019
With reference to your email dated asking for Bifurcation of Trade payable and cash flow statement, we herewith submitting revised Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2019 along with cash flow statement. Kindly take the same on your record. Thank you.22-11-2019
Trident Texofab Ltd - 540726 - Non-Applicability Of Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform you that disclosure under regulation 23(9) of SEBI(LODR) 2015 is not applicable to the company as the company is claiming exemption under regulation 15(2) of SEBI (LODR) 2015. Kindly take the above on record.18-11-2019
Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Trident Texofab Limited has submitted Press Release-Earning H1FY20. This is for your information and record. The same is being hosted on the company's website, viz. http://www.tridenttexofab.com/. Thanking You.08-11-2019
Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Trident Texofab Limited has submitted Press Release-Earning H1FY20. This is for your information and record. The same is being hosted on the company's website, viz. http://www.tridenttexofab.com/. Thanking You.08-11-2019
Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Meeting Updates
Trident Texofab Limited has submitted outcome of board meeting held on today commenced at 02.30 pm and concluded at 04.15 pm have inter-alia considered, approved and taken on record including unaudited financial result for the quarter and half year ended on September 30, 2019. Kindly take the above on record. Thank you.05-11-2019
Trident Texofab Ltd - 540726 - Financial Result For The Half Year Ended September 30, 2019
Trident Texofab Limited has submitted that the board of directors at its meeting held on today has approved unaudited financial result for the quarter and half year ended on September 30, 2019. Please find attached above unaudited financial result and limited review report. The meeting was commenced at 02.30 pm and concluded at 04.15 pm. Kindly take the same on your record. Thank you.05-11-2019
Trident Texofab Ltd - 540726 - Board Meeting Intimation for Inter Alia Including, To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2019.
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2019 ,inter alia, to consider and approve including, the unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2019. The trading window will remain closed for all designated persons covered under Company's Code of Conduct for Prevention of Insider Trading in Securities from October 01, 2019 to November 07, 2019 (both days inclusive). Kindly take the above on record.26-10-2019
Trident Texofab Ltd - 540726 - PCS Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015
Trident Texofab Limited has submitted PCS certificate under regulation 40(10) of SEBI (LODR) Regulations, 2015 for the half year ended on September 30, 2019. Kindly take the same on your record.22-10-2019
Trident Texofab Ltd - 540726 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Trident Texofab Limited has submitted certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30, 2019. Kindly take the same on your record. Thank you.16-10-2019